Eagle Asset Management Inc. decreased its stake in Aetna Inc. (NYSE:AET) by 9.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 343,035 shares of the company’s stock after selling 35,456 shares during the period. Eagle Asset Management Inc. owned 0.10% of Aetna worth $52,083,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the company. First Manhattan Co. raised its stake in Aetna by 3.6% in the first quarter. First Manhattan Co. now owns 4,300 shares of the company’s stock valued at $496,000 after buying an additional 150 shares in the last quarter. First Mercantile Trust Co. boosted its stake in shares of Aetna by 2.0% in the first quarter. First Mercantile Trust Co. now owns 2,423 shares of the company’s stock valued at $309,000 after buying an additional 47 shares during the period. IFP Advisors Inc boosted its stake in shares of Aetna by 93.2% in the first quarter. IFP Advisors Inc now owns 6,886 shares of the company’s stock valued at $878,000 after buying an additional 3,322 shares during the period. Breton Hill Capital Ltd. boosted its stake in shares of Aetna by 15.6% in the first quarter. Breton Hill Capital Ltd. now owns 7,013 shares of the company’s stock valued at $895,000 after buying an additional 946 shares during the period. Finally, Greenwich Wealth Management LLC boosted its stake in shares of Aetna by 1.6% in the first quarter. Greenwich Wealth Management LLC now owns 30,552 shares of the company’s stock valued at $3,897,000 after buying an additional 488 shares during the period. 89.57% of the stock is owned by institutional investors and hedge funds.

Shares of Aetna Inc. (NYSE AET) opened at 158.19 on Friday. The firm has a market capitalization of $52.53 billion, a P/E ratio of 35.11 and a beta of 0.53. The company’s 50-day moving average price is $155.64 and its 200-day moving average price is $142.91. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69.

Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 EPS. On average, equities research analysts expect that Aetna Inc. will post $9.54 EPS for the current fiscal year.

WARNING: “Eagle Asset Management Inc. Decreases Stake in Aetna Inc. (AET)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/09/02/eagle-asset-management-inc-decreases-stake-in-aetna-inc-aet.html.

Several brokerages have recently commented on AET. Royal Bank Of Canada raised their target price on Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Deutsche Bank AG raised their target price on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Finally, Morgan Stanley raised their target price on Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $157.99.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.90% of the stock is owned by corporate insiders.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.